Oak Associates’s Alkermes ALKS Stock Holding History

Oak Associates’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,100	Closed	-$257K	–	167
2016 Q3	$257K	Buy	+5,100	New	+$243K	0.03%	160

Other funds holding ALKS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Oak Associates's ALKS Position: Q4 2016 in Review

Oak Associates sold out of Alkermes (ALKS) in Q4 2016, closing a stake of 5,100 shares — an estimated $257K sold.

Oak Associates first reported a position in ALKS in Q3 2016 and held it in 1 quarter. The position peaked at $257K in Q3 2016. 267 funds tracked by Wall St. Rank hold ALKS as of Q4 2016.

Oak Associates reported no remaining Alkermes position as of Q4 2016 after selling out during the quarter.
Oak Associates sold 5,100 Alkermes shares in Q4 2016, an estimated $257K.
Oak Associates first reported a position in Alkermes in Q3 2016 and held it in 1 quarter.
Oak Associates's Alkermes position peaked at $257K in Q3 2016.
267 funds tracked by Wall St. Rank held Alkermes as of Q4 2016.

Based on Oak Associates's 13F filing for Q4 2016, filed 8 Feb 2017.